Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Phenoxyphenylacetic acid endothelin antagonist and its preparation method and application

A technology for phenoxyphenylacetic acids and endothelin antagonists, which is applied in the field of medicine and chemical industry, can solve the problems of low oral bioavailability of peptide antagonists, restrict the application of cardiovascular diseases, etc., and achieve strong endothelin receptor antagonistic activity. Effect

Active Publication Date: 2016-04-13
SOUTHEAST UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] At present, the peptide ET antagonists with strong effects have been found to include BQ123, BQ160, FR2139317, etc., but the low oral bioavailability of peptide antagonists limits their application in cardiovascular diseases requiring long-term medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phenoxyphenylacetic acid endothelin antagonist and its preparation method and application
  • Phenoxyphenylacetic acid endothelin antagonist and its preparation method and application
  • Phenoxyphenylacetic acid endothelin antagonist and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] The synthesis of embodiment 1α-bromonaphthalene ethyl acetate (3a)

[0057] Put 3.7g (0.02mol) of naphthaleneacetic acid into a 250mL eggplant-shaped bottle, dissolve it in 50mL of absolute ethanol, add 2mL of concentrated sulfuric acid, heat to reflux for 2 hours, and then cool. Then 2 / 3 of the excess ethanol was evaporated, 100 mL of water was added, the pH was adjusted to 7 with NaHCO3, extracted with ethyl acetate, the organic layer was washed twice with saturated brine, and dried over anhydrous magnesium sulfate. Anhydrous magnesium sulfate was filtered off, concentrated to give a light yellow oil, dissolved in 100mL CCl4, added 3.9g NBS and a small amount of benzoyl peroxide (BPO), heated to reflux for 4 hours, cooled, filtered, concentrated to get a yellow oil, 4.6 g, 80% yield in two steps.

Embodiment 24

[0058] The preparation of embodiment 24-methoxyphenyl α-ethyl chloroacetate (3d)

[0059] (1) Preparation of 4-methoxyphenyl α-glycolic acid

[0060] Dissolve 6ml (0.05mol) anisaldehyde in 16ml chloroform, add 1gTABA, stir and heat to reflux. At 56°C, 50% NaOH solution was added dropwise, and a khaki solid was formed. The reaction process temperature is controlled at 60-65°C. After the reaction is complete, add distilled water to dissolve and acidify with dilute HCl. Extracted with ethyl acetate, anhydrous MgSO 4 dry. Filter, evaporate to dryness, and recrystallize from toluene to obtain 6.4 g of 4-methoxyphenyl α-glycolic acid, with a yield of 70.3%.

[0061] (2) Preparation of 4-methoxyphenyl α-ethyl glycolate

[0062] Add 4.1g (0.023mol) of 4-methoxyphenyl α-glycolic acid, 50ml of ethanol, add 2ml of concentrated sulfuric acid, heat to reflux, distill off excess ethanol, add 100mL of water, adjust the pH to neutral with NAHCO3, then acetic acid extracted with ethyl e...

Embodiment 3

[0065] Synthesis of Example 32-hydroxyl-4-(2,1,3-benzothiadiazole 5-methoxy)acetophenone (2a)

[0066] (1) Synthesis of 5-methyl-2,1,3-benzothiadiazole

[0067] Add 46.5g (0.5mol) of freshly distilled aniline and 250ml of toluene to a 500ml three-necked flask, and slowly add 39.5ml (0.55mol) of SOCl dropwise under ice-cooling and stirring. 2 and 50ml of toluene, after the addition was completed, it was refluxed for 1 hour, at which point the reaction solution became a clear transparent solution. Cool to room temperature, add 30.5g (0.25mol) of 3,4-diaminotoluene, reflux for 6 hours under stirring, cool to room temperature, wash with dilute hydrochloric acid, saturated sodium bicarbonate solution and water successively, and dry over anhydrous magnesium sulfate. Filtrate, evaporate the solvent under reduced pressure to obtain a light yellow oily liquid, put it in the refrigerator for several hours, and precipitate white needle-shaped crystals, filter the yellow residual liquid ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention provides a phenoxy phenylacetic acid endothelin antagonist shown in a formula (I) or a pharmaceutically acceptable salt thereof, and also provides a preparation method of the benzene oxygen phenylacetic acid endothelin antagonist or the pharmaceutically acceptable salt thereof, and an application thereof in preparation of a medicament for treating cardiovascular and cerebrovascular diseases, tumors, diabetes mellitus, nephrosis, asthma or hyperthyroidism.

Description

technical field [0001] The invention belongs to the field of medicine and chemical industry, and particularly relates to a phenoxyphenylacetic acid endothelin antagonist, as well as its preparation method and application. Background technique [0002] The mortality rate of cardiovascular and cerebrovascular diseases ranks first among various diseases, and the final cause of death is overwhelmingly cardiac hypertrophy, heart failure (heart failure), stroke or fatal arrhythmia. Especially in recent years, the fatality rate of severe heart failure has remained high, which has become a difficult problem in the international medical community. These diseases currently lack effective therapeutic drugs. [0003] Endothelin (endothclin, ET) is an active polypeptide containing 21 amino acids synthesized and secreted by vascular endothelial cells, cardiac muscle, smooth muscle, etc. Injury factors play an important role in the pathogenesis of many heart, brain, lung, kidney and vasc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D285/14C07D317/54A61K31/433A61K31/36A61P9/00A61P35/00A61P3/10A61P13/12A61P11/06A61P5/16
CPCC07D285/14C07D317/54
Inventor 蔡进吉民
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com